Belgium

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector
30 May 2019

AB InBev IP exec explains how he is helping to shift attitudes one six-pack at a time

With the giant brewer facing off against Heineken in court, Michael Swita sets out how innovation and patents are becoming a far bigger consideration in the industry

4 Apr 2019

Daimler's Nokia complaint may throw light on how EU SEP communication is working

German car giant brings complaint against Finnish company in effort to get clarification around licensing of mobile standard essential patents in the auto sector

Refine content by:

Find an expert

Gottfried Schüll
Equity Partner
Dusseldorf, Germany
Cohausz & Florack